Company Filing History:
2 out of 6 
1 out of 832,880 Years Active: 2000-2003
Title: Nallaperumal Chidambaram: Innovator in Immunological Testing
Introduction
Nallaperumal Chidambaram is an accomplished inventor based in Dearborn Heights, MI (US). He holds a total of 3 patents that showcase his innovative contributions to the field of immunological testing. His work focuses on developing advanced testing apparatuses that utilize ionophore membranes for various applications.
Latest Patents
Chidambaram's latest patents include an immunologically based strip test utilizing ionophore membranes. This testing apparatus features an absorbent matrix that contains a membrane with a plurality of counter-ions. In this system, chromionophores (or fluorionophores) and affinophores compete to carry ions into the membrane, neutralizing the charge of the counter-ions. Biological recognition molecules bind to a portion of the affinophores, preventing them from entering the membrane. This mechanism allows more chromionophores (or fluorionophores) to enter the membrane. The portion of affinophores bound to the biological recognition molecules is inversely proportional to the concentration of the analyte in the solution or medium. Consequently, the color of the membrane-covered matrix changes in relation to the analyte's concentration. One notable application of this apparatus is a strip test for predicting ovulation.
Career Highlights
Throughout his career, Nallaperumal Chidambaram has worked with various companies, including Ia, Inc. His innovative work has significantly contributed to advancements in immunological testing technologies.
Collaborations
Chidambaram has collaborated with notable individuals in his field, including Judith Louise Erb and James G Downward, IV. These collaborations have further enriched his research and development efforts.
Conclusion
Nallaperumal Chidambaram is a prominent inventor whose work in immunological testing has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to improving testing methodologies.